-
1
-
-
7744241924
-
Adefovir dipivoxil: Review of a novel acyclic nucleoside analogue
-
DANTA M, DUSHEIKO G: Adefovir dipivoxil: review of a novel acyclic nucleoside analogue. Int. J. Clin. Pract. (2004) 58:877-886
-
(2004)
Int. J. Clin. Pract.
, vol.58
, pp. 877-886
-
-
Danta, M.1
Dusheiko, G.2
-
2
-
-
20344370977
-
MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in Type 2 diabetes
-
ERION MD, VAN POELJE PD, DANG Q et al.: MB06322 (CS-917): a potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in Type 2 diabetes. Proc. Natl Acad. Sci. USA (2005) 102:7970-7975.
-
(2005)
Proc. Natl Acad. Sci. USA
, vol.102
, pp. 7970-7975
-
-
Erion, M.D.1
Van Poelje, P.D.2
Dang, Q.3
-
3
-
-
0034614490
-
Signaling - 2000 and beyond
-
HUNTER T: Signaling - 2000 and beyond. Cell (2000) 100:113-127.
-
(2000)
Cell
, vol.100
, pp. 113-127
-
-
Hunter, T.1
-
4
-
-
0036181649
-
Protein tyrosine phosphatases: Structure and function, substrate specificity, and inhibitor development
-
ZHANG ZY: Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development. Ann. Rev. Pharmacol. Toxicol. (2002) 42:209-234.
-
(2002)
Ann. Rev. Pharmacol. Toxicol.
, vol.42
, pp. 209-234
-
-
Zhang, Z.Y.1
-
5
-
-
0033525870
-
Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene
-
ELCHEBLY M, PAYETTE P, MICHALISZYN E et al.: Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science (1999) 283:1544-1548.
-
(1999)
Science
, vol.283
, pp. 1544-1548
-
-
Elchebly, M.1
Payette, P.2
Michaliszyn, E.3
-
6
-
-
0033942614
-
Increased energy expenditures decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice
-
KLAMAN LD, BOSS O, PERONI OD et al.: Increased energy expenditures decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol. Cell Biol. (2000) 20:5479-5489.
-
(2000)
Mol. Cell Biol
, vol.20
, pp. 5479-5489
-
-
Klaman, L.D.1
Boss, O.2
Peroni, O.D.3
-
7
-
-
0037143754
-
PTP1B antisense Oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitiviy in diabetic mice
-
ZINKER BA, RONDINONE CM, TREVILLYAN JM et al.: PTP1B antisense Oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitiviy in diabetic mice. Proc. Natl. Acad. USA (2002) 99:11357-11362.
-
(2002)
Proc. Natl. Acad. USA
, vol.99
, pp. 11357-11362
-
-
Zinker, B.A.1
Rondinone, C.M.2
Trevillyan, J.M.3
-
9
-
-
0041809012
-
Protein tyrosine phosphatase 1B inhibition: Opportunities and challenges
-
LIU G: Protein tyrosine phosphatase 1B inhibition: opportunities and challenges. Curr. Med. Chem. (2003) 10:1407-1421.
-
(2003)
Curr. Med. Chem.
, vol.10
, pp. 1407-1421
-
-
Liu, G.1
-
11
-
-
10744228866
-
The development of potent non-peptidic PTP1B inhibitors
-
DUFRESNE C, ROY P, WANG Z et al.: The development of potent non-peptidic PTP1B inhibitors. Bioorg. Med. Chem. Lett. (2004) 14:1039-1042.
-
(2004)
Bioorg. Med. Chem. Lett.
, vol.14
, pp. 1039-1042
-
-
Dufresne, C.1
Roy, P.2
Wang, Z.3
-
12
-
-
7944224566
-
The role of protease activation of inflammation in allergic respiratory diseases
-
REED CE, KITA H: The role of protease activation of inflammation in allergic respiratory diseases. J Allergy Clin. Immunol. (2004) 114:997-1008.
-
(2004)
J Allergy Clin. Immunol.
, vol.114
, pp. 997-1008
-
-
Reed, C.E.1
Kita, H.2
-
14
-
-
24044436201
-
A novel, potent dual inhibitor of the leukocyte proteases cathepsin G and chymase
-
DE GARAVILLA L, GRECO MN, SUKUMAR N et al.: A novel, potent dual inhibitor of the leukocyte proteases cathepsin G and chymase. J. Biol. Chem. (2005) 280:18001-18007.
-
(2005)
J. Biol. Chem.
, vol.280
, pp. 18001-18007
-
-
De Garavilla, L.1
Greco, M.N.2
Sukumar, N.3
-
15
-
-
0019415752
-
Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus
-
KOLTERMAN OG, GRAY RS, GRIFFIN J et al.: Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. J. Clin. Invest. (1981) 68:957-969.
-
(1981)
J. Clin. Invest.
, vol.68
, pp. 957-969
-
-
Kolterman, O.G.1
Gray, R.S.2
Griffin, J.3
-
16
-
-
0024026298
-
The triumvirate: β cell, muscle, liver. A collusion responsible for NIDDM
-
DEFRONZO PA: The triumvirate: β cell, muscle, liver. A collusion responsible for NIDDM. Diabetes (1998) 37:667-687.
-
(1998)
Diabetes
, vol.37
, pp. 667-687
-
-
Defronzo, P.A.1
-
17
-
-
0024511329
-
Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM
-
CONSOLI A, NURJHAN N, CAPANI F, GERICH J: Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes (1989) 38:550-557.
-
(1989)
Diabetes
, vol.38
, pp. 550-557
-
-
Consoli, A.1
Nurjhan, N.2
Capani, F.3
Gerich, J.4
-
20
-
-
0035181809
-
Quantitative contributions of gluconeogenesis to glucose production during fasting in Type 2 diabetes mellitus
-
WAJNGOT A, CHANDRAMOULI V, SCHUMANN WC et al.: Quantitative contributions of gluconeogenesis to glucose production during fasting in Type 2 diabetes mellitus. Metabolism (2001) 50:47-52.
-
(2001)
Metabolism
, vol.50
, pp. 47-52
-
-
Wajngot, A.1
Chandramouli, V.2
Schumann, W.C.3
-
21
-
-
0005469667
-
Intracellular concentration and specific activity of carbohydrate-metabolizing enzymes. Application of specific radioimmunoassay
-
Veneziale CM (Ed.), University Park Press, Baltimore, USA
-
VENEZIALE CM, DONOFRIO JC, HANSEN JB, JOHNSON ML, MAZZOTTA MY: Intracellular concentration and specific activity of carbohydrate-metabolizing enzymes. Application of specific radioimmunoassay. In: The Regulation of carbohydrate Formation and Utilization in Mammals. Veneziale CM (Ed.), University Park Press, Baltimore, USA (1981):23-44.
-
(1981)
The Regulation of Carbohydrate Formation and Utilization in Mammals
, pp. 23-44
-
-
Veneziale, C.M.1
Donofrio, J.C.2
Hansen, J.B.3
Johnson, M.L.4
Mazzotta, M.Y.5
-
22
-
-
0026520193
-
Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis
-
PILKIS SJ, GRANNER DK: Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Ann. Rev. Physiol. (1992) 54:885-909.
-
(1992)
Ann. Rev. Physiol.
, vol.54
, pp. 885-909
-
-
Pilkis, S.J.1
Granner, D.K.2
-
23
-
-
0019568187
-
Inhibition of fructose-1,6-bisphosphatase by fructose-2,6-bisphosphate
-
VAN SCHAFTINGEN E, HERS HG: Inhibition of fructose-1,6-bisphosphatase by fructose-2,6-bisphosphate. Proc. Natl. Acad. Sci. USA (1981) 78:2861-2863.
-
(1981)
Proc. Natl. Acad. Sci. USA
, vol.78
, pp. 2861-2863
-
-
Van Schaftingen, E.1
Hers, H.G.2
-
24
-
-
0019887960
-
Inhibition of fructose-1,6-bisphosphatase by fructose-2,6-bisphosphate
-
PILKIS SJ, EL-MAGHRABI MR, PILKIS J, CLAUS T: Inhibition of fructose-1,6-bisphosphatase by fructose-2,6-bisphosphate. J. Biol. Chem. (1981) 256:3619-3622.
-
(1981)
J. Biol. Chem.
, vol.256
, pp. 3619-3622
-
-
Pilkis, S.J.1
El-Maghrabi, M.R.2
Pilkis, J.3
Claus, T.4
-
25
-
-
0023918674
-
Hormonal regulation of hepatic gluconeogenesis and glycolysis
-
PILKIS SJ, EL-MAGHRABI MR, CLAUS TH: Hormonal regulation of hepatic gluconeogenesis and glycolysis. Ann. Rev. Biochem. (1988) 57:755-783.
-
(1988)
Ann. Rev. Biochem.
, vol.57
, pp. 755-783
-
-
Pilkis, S.J.1
El-Maghrabi, M.R.2
Claus, T.H.3
-
26
-
-
0001683176
-
Allosteric inhibition of rat liver fructose-1,6-bisphosphate by adenosine 5′-monophosphate
-
TAKETA K, POGELL BM: Allosteric inhibition of rat liver fructose-1,6-bisphosphate by adenosine 5′-monophosphate. J. Biol. Chem. (1965) 240:651-662.
-
(1965)
J. Biol. Chem.
, vol.240
, pp. 651-662
-
-
Taketa, K.1
Pogell, B.M.2
-
27
-
-
0025883747
-
Conformational transition of fructose-1,6-bisphosphatase: Structure comparison between the AMP complex (T form) and the fructose 6-phosphate complex (R form)
-
KE H, LIANG JY, ZHANG Y, LIPSCOMB WN: Conformational transition of fructose-1,6-bisphosphatase: Structure comparison between the AMP complex (T form) and the fructose 6-phosphate complex (R form). Biochemistry (1991) 30:4412-4420.
-
(1991)
Biochemistry
, vol.30
, pp. 4412-4420
-
-
Ke, H.1
Liang, J.Y.2
Zhang, Y.3
Lipscomb, W.N.4
-
28
-
-
0028029482
-
Toward a mechanism for the allosteric transition of pig kidney fructose-1,6-bisphosphatase
-
ZHANG Y, LIANG JY, HUANG S, LIPSCOMB WN: Toward a mechanism for the allosteric transition of pig kidney fructose-1,6-bisphosphatase. J. Mol. Biol. (1994) 244:609-624.
-
(1994)
J. Mol. Biol.
, vol.244
, pp. 609-624
-
-
Zhang, Y.1
Liang, J.Y.2
Huang, S.3
Lipscomb, W.N.4
-
29
-
-
0038778445
-
3-(2-Carboxy-ethyl)-4,6-dichloro-1H-indole-2-carboxylic acid: An allosteric inhibitor of fructose-1,6-bisphosphatase bind at the AMP site
-
WRIGHT SW, CARLO AA, DANLEY DE et al.: 3-(2-Carboxy-ethyl)-4,6-dichloro-1H-indole-2-carboxylic acid: an allosteric inhibitor of fructose-1,6-bisphosphatase bind at the AMP site. Bioorg. Med. Chem. Lett. (2003) 13:2055-2058.
-
(2003)
Bioorg. Med. Chem. Lett.
, vol.13
, pp. 2055-2058
-
-
Wright, S.W.1
Carlo, A.A.2
Danley, D.E.3
-
30
-
-
0037194657
-
Anilinoquinazoline inhibitors of fructose-1,6-bisphosphatase bind at a novel allosteric site: Synthesis, in vitro characterization, and X-ray crystallography
-
WRIGHT SW, CARLO AA, CARTY MD et al.: Anilinoquinazoline inhibitors of fructose-1,6-bisphosphatase bind at a novel allosteric site: synthesis, in vitro characterization, and X-ray crystallography. J. Med. Chem. (2002) 45:3865-3877.
-
(2002)
J. Med. Chem.
, vol.45
, pp. 3865-3877
-
-
Wright, S.W.1
Carlo, A.A.2
Carty, M.D.3
-
31
-
-
0021723506
-
Stereoselective synthesis and biological activin of β- and α-D-arabinose 1,5-diphosphate: Analogues of a potent metabolic regulator
-
MARYANOFF BE, REITZ AB, TUTWILER GF, BENKOVIC SJ, BENKOVIC PA, PILKIS SJ: Stereoselective synthesis and biological activin of β- and α-D-arabinose 1,5-diphosphate: analogues of a potent metabolic regulator. J. Am. Chem. Soc. (1984) 106:7851-7853.
-
(1984)
J. Am. Chem. Soc.
, vol.106
, pp. 7851-7853
-
-
Maryanoff, B.E.1
Reitz, A.B.2
Tutwiler, G.F.3
Benkovic, S.J.4
Benkovic, P.A.5
Pilkis, S.J.6
-
32
-
-
0032501990
-
Preventing coronary heart disease: B vitamins and homocysteine
-
OMENN GS, BERESFORD SA, MOTULSKY AG: Preventing coronary heart disease: B vitamins and homocysteine. Circulation (1998) 97:421-424.
-
(1998)
Circulation
, vol.97
, pp. 421-424
-
-
Omenn, G.S.1
Beresford, S.A.2
Motulsky, A.G.3
-
33
-
-
0032501963
-
6 concentrations: Risk factors for stroke, peripheral vascular disease, and coronary artery disease
-
6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. Circulation (1998) 97:437-443.
-
(1998)
Circulation
, vol.97
, pp. 437-443
-
-
Robinson, K.1
Arheart, K.2
Refsum, H.3
-
34
-
-
12144260229
-
Control of hepatitis C: A medicinal chemistry perspective
-
GORDON CP, KELLER PA: Control of hepatitis C: a medicinal chemistry perspective. J. Med. Chem. (2005) 48: 1.
-
(2005)
J. Med. Chem.
, vol.48
, pp. 1
-
-
Gordon, C.P.1
Keller, P.A.2
-
35
-
-
0141426816
-
Targeting NS5B RNA-dependent RNA polymerase for anti-HCV chemotherapy
-
WU JZ, HONG Z: Targeting NS5B RNA-dependent RNA polymerase for anti-HCV chemotherapy. Curr. Drug Targets Infect. Disord. (2003) 3:207-219.
-
(2003)
Curr. Drug Targets Infect. Disord.
, vol.3
, pp. 207-219
-
-
Wu, J.Z.1
Hong, Z.2
-
36
-
-
17444388557
-
Design, synthesis, and antiviral activity of adenosine 5′-phosphonate analogues as chain terminators against hepatitis C virus
-
KOH Y, SHIM JH, WU JZ, ZHONG W, HONG Z, GIRARDET JL: Design, synthesis, and antiviral activity of adenosine 5′-phosphonate analogues as chain terminators against hepatitis C virus. J. Med. Chem. (2005) 48:2867-2875.
-
(2005)
J. Med. Chem.
, vol.48
, pp. 2867-2875
-
-
Koh, Y.1
Shim, J.H.2
Wu, J.Z.3
Zhong, W.4
Hong, Z.5
Girardet, J.L.6
-
38
-
-
0028819889
-
Mononucleoside phosphotriester derivatives with S-acyl-2-thioethyl bioreversible phosphates protecting groups: Intracellular delivery of 3′-azido-2′,3′-dideoxythymidine 5′-minophosphate
-
LEFEBVRE I, PERIGAUD C, POMPON A et al.: Mononucleoside phosphotriester derivatives with S-acyl-2-thioethyl bioreversible phosphates protecting groups: Intracellular delivery of 3′-azido-2′,3′-dideoxythymidine 5′-minophosphate. J. Med. Chem. (1995) 38:3941-3950.
-
(1995)
J. Med. Chem.
, vol.38
, pp. 3941-3950
-
-
Lefebvre, I.1
Perigaud, C.2
Pompon, A.3
-
39
-
-
11144357250
-
450 3A-activated prodrugs (HepDirect prodrugs) useful for targeting phosph(on)ate-based drugs to the liver
-
450 3A-activated prodrugs (HepDirect prodrugs) useful for targeting phosph(on)ate-based drugs to the liver. J. Am. Chem. Soc. (2004) 126:5154-5163.
-
(2004)
J. Am. Chem. Soc.
, vol.126
, pp. 5154-5163
-
-
Erion, M.D.1
Reddy, K.R.2
Boyer, S.H.3
-
41
-
-
0027284753
-
Intracellular delivery of bioactive AZT nucleotides by aryl phosphate derivatives of AZT
-
MCGUIGAN C, PATHIRANA RN, BALZARINI J, DE CLERCQ E: Intracellular delivery of bioactive AZT nucleotides by aryl phosphate derivatives of AZT. J. Med. Chem. (1993) 36:1048-1052.
-
(1993)
J. Med. Chem.
, vol.36
, pp. 1048-1052
-
-
Mcguigan, C.1
Pathirana, R.N.2
Balzarini, J.3
De Clercq, E.4
|